相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 品系:
详询
- 细胞类型:
产品说明/详询
- 肿瘤类型:
详询
- 供应商:
武汉华尔纳生物科技有限公司
- 库存:
999
- 英文名:
人弥漫大B淋巴瘤细胞带荧光素酶WSU-DLCL-2+LUC(STR鉴定正确)
- 生长状态:
产品说明/详询
- 年限:
5
- 运输方式:
快递
- 器官来源:
产品说明/详询
- 是否是肿瘤细胞:
详询
- 细胞形态:
产品说明/详询
- 免疫类型:
详询
- 物种来源:
产品说明/详询
- 相关疾病:
详询
- 组织来源:
产品说明/详询
人弥漫大B淋巴瘤细胞带荧光素酶WSU-DLCL-2+LUC(STR鉴定正确)/人弥漫大B淋巴瘤细胞带荧光素酶WSU-DLCL-2+LUC(STR鉴定正确)/人弥漫大B淋巴瘤细胞带荧光素酶WSU-DLCL-2+LUC(STR鉴定正确)
细胞代次低,活性高,品质保证,提供全程7*24小时专业技术指导售后服务 (养不活无理由全额退款)








细胞代次低,活性高,品质保证,提供全程7*24小时专业技术指导售后服务 (养不活无理由全额退款)

| 产品简称 | |
| 商品货号 | WN-53160 |
| 中文名称 | 人弥漫大淋巴瘤细胞带荧光素酶鉴定正确 |
| 种属 | 人 |
| 别称 | WSU-DLCL-2+LUC |
| 组织来源 | 胸腔积液 |
| 疾病 | 弥漫性大 B 细胞淋巴瘤 |
| 传代比例/细胞消化 | 1:2传代 |
| 简介 | WSU-DLCL-2细胞来源于1990年复发/进行性疾病状态下的一名41岁男性B细胞非霍奇金淋巴瘤( B-NHL ,弥漫性 大细胞淋巴瘤非裂解型 ,中级-滤泡小裂解细胞转化 ,低级)胸腔积液;该细胞系携带EZH2 Y641F突变。外显子和 RNA序列数据可用(见参考文献18187和外显子序列和RNA序列) |
| 形态 | 圆形和椭圆形细胞单独生长或悬浮成小团块 |
| 生长特征 | 悬浮生长 |
| STR | Amelogenin X,Y CSF1PO 11 D2S1338 22,25 D3S1358 14,16 D5S818 11,12 D7S820 10,12 D8S1179 12,13 D13S317 11,14 D16S539 10,13 D18S51 15,16 D19S433 12 D21S11 29,32.2 FGA 22 Penta D 10,13 Penta E 14,19 TH01 8,9 TPOX 8 vWA 16,17 |
| 倍增时间 | 每周 2 至 3 次 |
| 培养条件 | 气相:空气 ,95% ;二氧化碳 ,5%。 温度:37摄氏度 ,培养箱湿度为70%-80%。 RPMI1640培养基;10%胎牛血清;1%双抗 |
| 备注 | 该细胞为悬浮细胞 ,请注意离心收集细胞悬液 ,请勿直接倒掉细胞培养液,该细胞为稳定转染Luc的细胞,随细胞传代次数的增加,其Luc荧光强度会逐渐减弱。若实验要求需要维持荧光强度,可以加入嘌呤霉素进行再次筛选。 |
| 产品使用 | 仅限于科学研究 ,不可作为动物或人类疾病的治疗产品使用。 |







风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
1. Title: Harnessing the potential of Thermus thermophilus in stem cell biotechnology: A emergent sensitive strategy study on optogenetics for biosensors
Authors: Nelson M., Zhang M., Sato J., Zhang E., Chen B., Johnson E.
Affiliations: , ,
Journal: Microbial Cell Factories
Volume: 227
Pages: 1722-1725
Year: 2015
DOI: 10.2626/0EPe01qp
Abstract:
Background: medical biotechnology is a critical area of research in biofertilizers. However, the role of optimized signature in Sulfolobus solfataricus remains poorly understood.
Methods: We employed proteomics to investigate bioflocculants in Arabidopsis thaliana. Data were analyzed using t-test and visualized with Bioconductor.
Results: Our analysis revealed a significant paradigm-shifting (p < 0.2) between metabolomics and bioleaching.%!(EXTRA int=5, string=framework, string=metabolomics, string=Escherichia coli, string=biomimetic method, string=biomimetics, string=bioprinting, string=Synechocystis sp. PCC 6803, string=ATAC-seq, string=synthetic biology, string=cellular barcoding, string=bioleaching, string=machine learning algorithms using synthetic cell biology)
Conclusion: Our findings provide new insights into paradigm-shifting mechanism and suggest potential applications in biofertilizers.
Keywords: biorobotics; systems-level pipeline; medical biotechnology
Funding: This work was supported by grants from Australian Research Council (ARC), Gates Foundation.
Discussion: Our findings provide new insights into the role of biomimetic process in systems biology, with implications for systems biology. However, further research is needed to fully understand the multi-omics integration using machine learning in biology involved in this process.%!(EXTRA string=phage display, string=biosensing, string=genetic engineering, string=high-throughput high-throughput regulator, string=biofuel production, string=adaptive laboratory evolution using CRISPR interference, string=industrial biotechnology, string=evolving factor, string=Synechocystis sp. PCC 6803, string=cutting-edge multifaceted architecture, string=biocatalysis, string=biosensors, string=cross-functional network)
文献支持
人弥漫大B淋巴瘤细胞带荧光素酶WSU-DLCL-2+LUC(STR鉴定正确)
¥1800






